ReviewTherapeutic advances in gastroenterology2023

Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis.

Qiong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.